Nantahala Capital Management, LLC Q3 2021 Filing

Filed November 15, 2021

Portfolio Value

$3.2B

Holdings

123

Report Date

Q3 2021

Filing Type

13F-HR

All Holdings (123 positions)

#	Stock	Shares	Value	% Portfolio	Type
101	—HTG MOLECULAR DIAGNOSTICS IN	347,171	$2.0M	0.06%
102	UNCYUNICYCIVE THERAPEUTICS INC	700,000	$2.0M	0.06%
103	—ELOXX PHARMACEUTICALS INC	1,209,338	$2.0M	0.06%
104	—5 01 ACQUISITION CORP	185,213	$1.8M	0.06%
105	RGSUSDREGIS CORP MINN	515,268	$1.8M	0.06%	Put
106	CRBUCARIBOU BIOSCIENCES INC	56,418	$1.3M	0.04%
107	TNGXTANGO THERAPEUTICS INC	100,000	$1.3M	0.04%
108	—PERELLA WEINBERG PARTNERS	400,000	$1.3M	0.04%
109	—ANGION BIOMEDICA CORP	118,521	$1.2M	0.04%
110	TACTTRANSACT TECHNOLOGIES INC	76,583	$1.1M	0.03%
111	GLMDGALMED PHARMACEUTICALS LTD	374,730	$1.0M	0.03%
112	IMTXIMMATICS N.V	226,471	$958K	0.03%
113	—FINTECH ACQUISITION CORP V	333,331	$697K	0.02%
114	—KINTARA THERAPEUTICS INC	663,279	$582K	0.02%
115	GFAIGUARDFORCE AI CO LTD	600,000	$480K	0.02%
116	—METROMILE INC	558,296	$475K	0.01%
117	—INSU ACQUISITION CORP III	333,332	$292K	0.01%
118	—FTAC HERA ACQUISITION CORP	249,997	$257K	0.01%
119	—TELIGENT INC NEW	525,952	$207K	0.01%
120	—ROTH CH ACQUISITION III CO	99,749	$128K	0.00%
121	—FALCON MINERALS CORP	878,022	$127K	0.00%
122	—CYREN LTD	152,393	$95K	0.00%
123	—AVENUE THERAPEUTICS INC	30,211	$45K	0.00%

PreviousPage 2 of 2